Loading…
← CockpitCompetitor Analysis › 688787.SS Beijing Haitian Ruisheng Science Technology Co. Ltd. Class AOpen in the cockpit ↗

Beijing Haitian Ruisheng Science Technology Co. Ltd. Class A688787.SSCompetitor analysis, valuation and peers

China · CNY·Industrials›Miscellaneous Commercial Services
Momentum weak 34
Mkt cap
$801M
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$163M
20-day average traded
Fwd P/E
126.5×
forward earnings
ROIC−WACC
-7.0 pp
WACC 12.1%
Hurdle
n/a
no reverse DCF
Next earnings
156 days
23 Apr 2027
Close · CNYCN¥91.29
1D-2.2%
1W-37.3%
1M-11.8%
3M-16.8%
6M-36.5%
YTD-21.3%
1Y-23.0%
ATR %13.9%
52w lowhigh53.9% off high

What Beijing Haitian Ruisheng Science Technology does

Employees: 262

Beijing Haitian Ruisheng Science Technology at a glance

Size Beijing Haitian Ruisheng Science Technology (688787.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $801M, the 2580th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥91.29 on 18 Nov 2026.

Performance Over six months the shares fell 36.5%, against -3.0% for the median peer and -20.0% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.

Growth Revenue grew 34.5% over the last twelve months (peer median +4.5%); the operating margin is 4.2% (peer median 9.7%).

Valuation It trades at 126.5× forward earnings against a peer median of 17.7× (most expensive of 16).

Capital Return on invested capital runs 7.0 points below its cost of capital (12.1% WACC).

Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026Peer median 98688787.SS 62
Six months, rebased to 100: Beijing Haitian Ruisheng Science Technology against the median of its 20 peers (local-currency closes).

Beijing Haitian Ruisheng Science Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥433MCN¥376MCN¥236MCN¥169MCN¥261M
Revenue growth—+60%+39%-35%—
Gross profitCN¥208MCN¥160MCN¥137MCN¥79.2MCN¥161M
EBITDAn/aCN¥28.1MCN¥18.6M-CN¥47.7MCN¥475,470
Net incomeCN¥20.4MCN¥14.1MCN¥11.3M-CN¥30.4MCN¥29.5M
Free cash flow-CN¥34.2M-CN¥26.2MCN¥3.93M-CN¥46.9M-CN¥214M
Capital expenditureCN¥65.6MCN¥33.2MCN¥31.4MCN¥25.9MCN¥257M
Total debtCN¥10.6MCN¥17.9MCN¥5.03MCN¥7.77MCN¥0

Quarterly statements and history in the cockpit →

Beijing Haitian Ruisheng Science Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%BVMTRI9715KAR6033730009K0TASK002649603955688530IBEXIPO6883343008600012079716CCL688787.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Beijing Haitian Ruisheng Science Technology is the large dot.

Fundamentals: revenue growth against valuation

-40%-20%0%+20%+40%0×50×100×BV9715KAR603373TASKIBEXIPO3008600012079716CCL688787.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Beijing Haitian Ruisheng Science Technology is the large dot.

Beijing Haitian Ruisheng Science Technology competitors and peer comparison

How Beijing Haitian Ruisheng Science Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Beijing Haitian Ruisheng Science Technology against its 20 peers (data as of 18 Nov 2026)
Measure688787.SSPeer medianRank in peer set
1-month return-11.8%-4.2%5th lowest of 21
6-month return-36.5%-3.0%3rd lowest of 21
Distance from 52-week high-53.9%-27.9%4th lowest of 21
Revenue growth (TTM)+34.5%+4.5%4th highest of 21
Operating margin4.2%9.7%8th lowest of 21
Forward P/E126.5×17.7×most expensive of 16
ROIC minus cost of capital-7.0 pp+3.1 pp6th lowest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Beijing Haitian Ruisheng Science Technology 688787.SSChina$801M-37%+34%4%126.5×n/an/a
BrightView BVUnited States$803M-29%+1%4%19.6×n/an/a
Mentari Therapeutics MTRIUnited States$807M-91%-83%-1,239%n/an/an/a
transcosmos 9715.TJapan$814M-11%+6%4%10.1×-18.2%+3.2%
Karnov KAR.STSweden$820M+9%-4%20%20.6×5.1%+27.9%
Anbang Save-Guard 603373.SSChina$779M+6%-1%14%38.9×5.6%+5.6%
Aimed Bio 0009K0.KSSouth Korea$778M-61%+228%34%n/a10.2%+652.2%
TaskUs TASKUnited States$827M+50%+9%12%6.5×1.3%+19.9%
Beyondsoft 002649.SZChina$769M-14%-6%2%24.1×7.0%+9.2%
Daqian Ecology & Environment 603955.SSChina$769M+21%+217%-53%n/an/an/a
Omat Advanced Materials (Guangdong) 688530.SSChina$757M-19%+82%9%n/an/an/a
Shaanxi Fenghuo Electronics 000561.SZChina$851M-27%+8%-26%n/an/an/a
IBEX IBEXUnited States$744M+79%+15%9%13.5×1.0%+7.7%
IP Group plc IPO.LUnited Kingdom$865M+11%-37%51%12.0×n/an/a
Xi'an High Voltage Apparatus Research Institute 688334.SSChina$866M-11%+4%29%20.7×-2.9%+20.3%
Funshine Culture 300860.SZChina$739M0%-49%-35%24.2×21.5%-24.6%
AXISCADES Technologies AXISCADES.NSIndia$871M-6%+5%10%17.7×n/an/a
Shandong Link Science and Technology 001207.SZChina$733M-24%+7%13%11.6×-5.5%+18.9%
NOMURA 9716.TJapan$880M+7%-10%7%14.6×-7.5%+8.6%
Cuscal CCL.AXAustralia$728M+17%+19%12%18.1×n/an/a
Funai Soken 9757.TJapan$724M+10%+5%25%16.2×-8.7%+5.9%

Questions

Which companies are Beijing Haitian Ruisheng Science Technology's closest peers?
The cockpit's peer set: BrightView (BV), Mentari Therapeutics (MTRI), transcosmos (9715.T), Karnov (KAR.ST), Anbang Save-Guard (603373.SS), Aimed Bio (0009K0.KS), TaskUs (TASK), Beyondsoft (002649.SZ).
Is Beijing Haitian Ruisheng Science Technology expensive compared with its peers?
On forward p/e it trades at 126.5× against a peer median of 17.7×, most expensive of 16 in its peer set.
How has Beijing Haitian Ruisheng Science Technology stock performed?
Over six months to 18 Nov 2026 the shares returned -36.5% against -3.0% for the median peer; over one year -23.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.